If COX-2-derived PGE2 signaling modulates the NO2-mediated aggravation of AD progression and if MAGL inhibition prevents the PGE2 release after the COX-2-mediated conversion of AA, MAGL disruption should suppress Aβ accumulation and reverse cognitive deterioration following exposure to NO2. The gene discussed is PTGS2; the disease is Alzheimer disease.